TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+16.47%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.4B
AUM Growth
+$1.4B
(+43%)
Cap. Flow
+$313M
Cap. Flow
% of AUM
22.32%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
163
New
35
Increased
43
Reduced
14
Closed
8
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$32.6M |
| 2 |
BioNTech
BNTX
|
$32.1M |
| 3 |
Relay Therapeutics
RLAY
|
$25.3M |
| 4 |
ITOS
iTeos Therapeutics
ITOS
|
$24.6M |
| 5 |
Immunocore
IMCR
|
$21.8M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$24.4M |
| 2 |
Dynavax Technologies
DVAX
|
$6.68M |
| 3 |
Beam Therapeutics
BEAM
|
$2.45M |
| 4 |
Inhibrx
INBX
|
$2.37M |
| 5 |
CRISPR Therapeutics
CRSP
|
$2.35M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Technology | 1.47% |
| 3 | Communication Services | 1.22% |
| 4 | Real Estate | 0.34% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
BioAtla
BCAB
$28.7M
| $1.54M | 0.11% |
874,076
-500,000
| -36% | -$880K |
|
102
Erasca
ERAS
$406M
| $1.37M | 0.1% |
502,915
-47,085
| -9% | -$129K |
|
103
Enanta Pharmaceuticals
ENTA
$189M
| $1.31M | 0.09% |
126,655
-173,345
| -58% | -$1.8M |
|
104
OmniAb
OABI
$219M
| $1.27M | 0.09% |
300,000
| – | – |
|
|
ATYR
105
aTyr Pharma
ATYR
$560M
| $1.18M | 0.08% |
671,134
| – | – |
|
106
Astria Therapeutics
ATXS
$394M
| $1.1M | 0.08% |
100,000
| – | – |
|
107
Passage Bio
PASG
$22.7M
| $1.05M | 0.08% |
1,500,000
| – | – |
|
108
Walmart
WMT
$793B
| $1.03M | 0.07% |
12,725
+8,265
| +185% | +$667K |
|
109
JPMorgan Chase
JPM
$824B
| $985K | 0.07% |
4,673
+2,862
| +158% | +$603K |
|
110
Microsoft
MSFT
$3.76T
| $968K | 0.07% |
2,250
+1,436
| +176% | +$618K |
|
111
Berkshire Hathaway Class B
BRK.B
$1.08T
| $957K | 0.07% |
2,079
+1,368
| +192% | +$630K |
|
112
Home Depot
HD
$406B
| $954K | 0.07% |
2,354
+1,675
| +247% | +$679K |
|
113
Pacira BioSciences
PCRX
$1.22B
| $921K | 0.07% |
+61,226
| New | +$921K |
|
114
Verizon
VZ
$184B
| $916K | 0.07% |
20,401
+15,093
| +284% | +$678K |
|
115
Visa
V
$681B
| $912K | 0.07% |
3,318
+2,269
| +216% | +$624K |
|
116
NextCure
NXTC
$13.3M
| $894K | 0.06% |
652,386
+49,392
| +8% | +$67.7K |
|
117
Procter & Gamble
PG
$370B
| $891K | 0.06% |
5,145
+3,602
| +233% | +$624K |
|
118
Coca-Cola
KO
$297B
| $889K | 0.06% |
12,373
+8,812
| +247% | +$633K |
|
119
Texas Instruments
TXN
$178B
| $868K | 0.06% |
4,202
+2,998
| +249% | +$619K |
|
120
PayPal
PYPL
$66.5B
| $866K | 0.06% |
+11,099
| New | +$866K |
|
121
Intel
INTC
$105B
| $858K | 0.06% |
36,572
+29,218
| +397% | +$685K |
|
122
Viatris
VTRS
$12.3B
| $858K | 0.06% |
73,881
+51,801
| +235% | +$601K |
|
123
Walt Disney
DIS
$211B
| $850K | 0.06% |
8,834
+6,805
| +335% | +$655K |
|
124
Nike
NKE
$110B
| $843K | 0.06% |
+9,539
| New | +$843K |
|
125
UnitedHealth
UNH
$279B
| $831K | 0.06% |
+1,422
| New | +$831K |
|